New to The Street TV Announces Corporate Interviews on its

0
101


NEW YORK, Sept. 26, 2022 (GLOBE NEWSWIRE) — FMW Media’s New to The Street TV, a nationally syndicated TV present, broadcasts episode #390 airing tonight, Monday, September 26, 2022, at 10:30 PM PT on the Fox Business Network.

New to The Street’s 390th TV episode options the next Companies and their representatives:

1). PetVivo Holdings, Inc.’s (NASDAQ: PETV) (NASDAQ: PETVW) ($PETV) interview with John Lai, CEO & President.

2). Acurx Pharmaceuticals, Inc.’s (NASDAQ: ACXP) ($ACXP) interview with David Luci, President / CEO.

3). Sekur Private Data, Ltd.’s (OTCQX: SWISF) (CSE: SKUR) (FRA: GDT0) interview with Mr. Alain Ghiai, CEO.

4). Phixey, Inc.’s interview with Alexandra Poirier, Communications Manager.

Episode #390

Tonight, New to The Street TV is airing the Nasdaq Marketplace studio interview with John Lai, CEO / President PetVivo Holdings, Inc. (NASDAQ: PETV) (NASDAQ: PETVW) ($PETV). The Company is a biomedical machine firm that manufactures, commercializes, and licenses modern medical gadgets and therapeutics for companion animals. Talking with TV Host Jane King, John provides viewers an replace on the current launch of the distribution settlement between PETV and MWI Animal Health (MWI), a number one animal well being services distributor, and Amerisource Bergen subsidiary. With over $5B in annual income, MWI is likely one of the largest distributors of veterinary medicine and merchandise, with a lot of business assets and expert personnel. Securos is the academic division at MWI, which supplies hands-on coaching, assets, and persevering with schooling for veterinarians, serving to them perceive the complete advantages of merchandise. The academic and gross sales/ market groups at MWI now promote and distribute PETV’s injectable patented Spryng with OsteoCushion Technology that treats osteoarthritis and joint afflictions for canine, horses, and cats. As a naturally derived product, Spryng mimics collagen tissue that considerably improves animals’ troubled joints. The feline osteoarthritis model of Spryng is coming to market quickly. John says the Spryng roll-out with MWI goes very nicely. He explains three causes for Spryng continued progress: 1) it’s a naturally derived product, 2) it isn’t a pharmaceutical or organic derived product, and three) it has a recyclable package deal according to ESG (Environmental, Social, and Governance) requirements. Recently, PETV employed extra seasoned personnel with over twenty years of gross sales/advertising and marketing expertise within the pet business. The on-screen QR code is out there throughout the present; obtain or go to PetVivo Holdings, Inc. https://petvivo.com/ and Spryng with OsteoCushion Technology https://www.sprynghealth.com/.

On New to The Street TV tonight, David Luci, the President / CEO of Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ($ACXP), sits with TV Host Jane King from the Nasdaq Marketplace studio. Acurx Pharmaceuticals, Inc. is a medical biopharmaceutical business, growing a brand new class of antibiotics for bacterial infections. David discusses the Company’s novel Ibezapolstat drug, a possible therapy for Clostridioides difficile Infections (C. difficile) (CDI). Treatments to fight CDI is a $1.7B 12 months market. With the current constructive end result from Ibezapolstat’s FDA Phase 2a medical and microbiome information, the Company is now enrolling sufferers for its FDA Phase 2b trial. CDI kills about 29,000 individuals yearly; many catch the an infection in hospitals and nursing properties. Clinical information to date exhibits that Ibezapolstat will increase the great microbiome micro organism within the intestine, and it demonstrated eradication of CDI throughout 3-days of therapy. David references Summit Therapeutics, and their current Phase 3 FDA failure on a aggressive CDI drug. There has been NO new class of antibiotic medicine since 1984, and the present frontline therapy Vancomycin, has limitations with a couple of 15-20% charge of CDI recurrence. Big Pharma desires a brand new class of antibiotics to fight CDI and different bacterial infections. The second drug in ACXP’s pipeline is ACX-375C, a possible drug to overcome methicillin-resistant Staphylococcus aureus (MRSA) infections. Disease information exhibits that MRSA accounts for 52% of US hospital inpatient infections. Based on early scientific information, ACXP’s administration will proceed with all of the FDA steps on AXX-375C with the hope of change into one other helpful drug. David explains that being public is important and helps the Company increase cash, as wanted, going ahead with present and different pipeline therapies. David will do a follow-up interview to inform viewers of the progress with the Ibezapolstat drug and the Company. The on-screen QR code is out there throughout the present; obtain or go to Acurx Pharmaceticals, Inc.https://www.acurxpharma.com/

See also  Ascent Solar Announces Board and Executive Leadership

Tonight, Mr. Alain Ghiai, CEO, Sekur Private Data, Ltd. (OTCQX: SWISF) (CSE: SKUR) (FRA: GDT0) ($SWISF) (Sekur®), is with New to The Street’s TV Host Jane King. Viewers obtain an summary of the profitable Q2 company monetary fundamentals primarily based on promoting its Sekur® cybersecurity merchandise. Alain instructed viewers that gross sales elevated over 1100% for Q2 ending June 30, 2022, in contrast to Q2, 2021. And the Q3 numbers look to exceed that of Q2. The Company has good cash-on-hand of $4M, no debt, and expects operational profitability someday in 2023. With will increase in new subscribers, up 800% year-to-date, and the prevailing subscribers buying extra licenses, the income expectations look to be round 200% greater in 2022 than in 2021. Revenue progress continues to be robust, with solely a small variety of subscribers canceling companies. Sekur reduces advertising and marketing prices with in-house search engine marketing advertising and marketing personnel. The Company will not be utilizing 3rd celebration search engine marketing entities. The monetary matrix in Q2 efficiently confirmed that Sekur’s SaaS (Software a as Service) business mannequin is working nicely with robust upward momentum. Alain informs viewers that profitability is probably going primarily based on present subscription charges and anticipated gross sales progress to proceed all through 2023. Sekur Private Date, Ltd. expects to announce three company partnerships with a digital media firm, an e-commerce entity, and a B2B cyber platform that competes with Shopify. The 2023 profitability expectation doesn’t account for the anticipated subscription proportion improve that may come from these partnerships. If solely a 1/3 of the expectations subscribe from these companions, operational profitability will come earlier than anticipated in 2023. Alain expects to develop its small business subscription base in 2023 with cost-efficient safety merchandise. With the persistent and elevated hacking of non-public information and privateness breaches on people and companies, Sekur is getting new subscribers for its e-mail, textual content, and different encrypted platforms. Viewers can study extra concerning the Company’s e-mail, textual content, and extra encrypted safety platforms by means of video tutorials posted on the Company’s web site. Remember: Sekur operates its web platforms and safety companies underneath the nation of Switzerland’s very robust privateness legal guidelines. The on-screen QR code is out there throughout the present; obtain or go to Sekur Private Data, Ltd. – https://www.sekurprivatedata.com/ and http://www.Sekur.com.

See also  Shooting of Bhojpuri film 'Shola Shabnam-2' will start in Basti city

Tonight from the Nasdaq Marketplace studio, Alexandra Poirier, Communications Manager of Phixey, Inc. talks with New to the Street’s TV Host Jane King about Phixey, Inc., an electronics membership that repairs gadgets and affords different membership perks. The foremost membership profit is a tool mounted for “FREE.” Like AAA for automobile members, Phixey affords its members advantages and digital service restore choices on gadgets. In business for 15 years, Phixey is a disrupter within the digital machine restore service business, providing a membership charge as little as $19.95 per 12 months, $1.66 a month. The digital service restore business is a billion-dollar-a-year business, and Phixey is the one entity on the earth that gives one of these digital membership membership. Cell telephone breakage occurs typically; the glass display is fragile. Phixey members get these screens repaired “FREE.” The present common value of cellphone repairs ranges from $150-$800. The solely value to a Phixey member is the yearly- charge. The membership’s companies usually are not a part of an insurance coverage plan and haven’t any deductibles. Cell telephones, laptops, computer systems, digital wearables, and tablets can have a membership, and every machine has its proprietor membership to benefit from the membership’s advantages. Another upcoming profit is the Phixey Wireless cellphone plan, limitless discuss and textual content for $10.00, hosted on T-Mobile. Also, members get a reduction on equipment with free delivery or a 25% off at affiliate retailers. Viewers who need to change into members can be a part of by going to the web site: https://phixey.com/Membership. Once a member and your machine change into damaged, you log again into the web site and request service, and Phixey supplies a technician in your space. With over 2M members anticipated to be a part of the Phixey Club, it expects to be a family model identify with everybody. The Company will not be public, however it could actually settle for direct investments. To study extra, ship an e-mail to data@phixey.com with the title in e-mail “Investment Opportunity.” The on-screen QR code is out there throughout the present; obtain or go to Phixey, Inc.https://phixey.com.

About PetVivo Holdings, Inc. (NASDAQ: PETV) (NASDAQ: PETVW) ($PETV):

PetVivo Holdings Inc. (NASDAQ: PETV) (NASDAQ: PETVW) ($PETV) is an rising biomedical machine firm targeted on manufacturing, commercializing, and licensing modern medical gadgets and therapeutics for companion animals. The Company’s technique is to leverage human therapies for treating companion animals cost-effectively and time-efficiently. An important part of this technique is the accelerated timeline to revenues for veterinary medical gadgets, which enter the market a lot sooner than extra stringently regulated prescription drugs and biologics. PetVivo has a pipeline of seventeen merchandise for the therapy of animals and other people. A portfolio of 19 patents protects the Company’s biomaterials, merchandise, manufacturing processes, and strategies of use. The Company’s lead product SPRYNG with OsteoCushion expertise, a veterinarian-administered, intraarticular injection for the administration of lameness and different joint-related afflictions, together with osteoarthritis, in canine and horses, is at the moment accessible for business sale – https://petvivo.com/.

See also  Pharming Announces US FDA Acceptance for Priority Review of its New Drug Application for Leniolisib

About Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ($ACXP):

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ($ACXP) is a clinical-stage biopharmaceutical Company targeted on growing new antibiotics for difficult-to-treat infections. The Company’s method is to develop antibiotic candidates that focus on the DNA polymerase IIIC enzyme. Its R&D pipeline consists of antibiotic product candidates that focus on Gram-positive micro organism, together with Clostridioides difficile, methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE), and drug-resistant Streptococcus pneumoniae (DRSP). The Company’s Ibezapolstat is a novel, orally administered antibiotic developed as a Gram-Positive Selective Spectrum (GPSS™) antibacterial.  It is the primary of a brand new class of DNA polymerase IIIC inhibitors underneath growth by Acurx to deal with bacterial infections.  Ibezapolstat’s distinctive spectrum of exercise, which incorporates C. difficile however spares different Firmicutes and the essential Actinobacteria phyla, seems to contribute to sustaining a wholesome intestine microbiome. The Company accomplished Phase 1 and Phase 2a medical trials of ibezapolstat. To study extra about Acurx Pharmaceuticals and its product pipeline, please go to www.acurxpharma.com.

About Phixey, Inc.:

Phixey, Inc., an digital restore business for over 15 years, helps clients with their cellphone, pill, and laptop computer service wants. The Company has agreements with DrPhoneFix, Techy, Experimax, and InMovement, totaling about 300 shops worldwide. Customers haven’t any limits to the place they’ll go to get their digital gadgets repaired.  Device homeowners can have peace of thoughts that their gadgets keep protected with out excessive restore prices, month-to-month premiums, and excessive deductibles. Phixey is just a membership for cellphone, pill, laptop computer, laptop, and wearable homeowners that offers you great advantages. With Phixey, Inc., the times of excessive restore prices, month-to-month premiums, and ridiculous deductibles are out – https://phixey.com/.

About FMW Media: 

FMW Media operates one of many longest-running US and International sponsored and Syndicated Nielsen Rated programming TV manufacturers, “New to The Street,” and its blockchain present, “Exploring The Block.” Since 2009, these manufacturers have run biographical interview section exhibits throughout main U.S. Television networks. The paid-for-TV programming platforms can doubtlessly attain over 540 million properties within the US and worldwide markets. FMW’s New to The Street / Newsmax TV broadcasting platform airs its syndication on Sundays at 10 -11 AM ET. FMW can be one of many nation’s largest patrons of linear tv, lengthy and short-form paid programming – https://www.newsmaxtv.com/Shows/New-to-the-Street & https://www.newtothestreet.com/.

Forward-Looking Statements Disclaimer:

This press launch accommodates forward-looking statements inside Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. In some instances, you’ll be able to determine forward-looking statements by the next phrases: “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “ongoing,” “plan,” “potential,” “predict,” “project,” “should,” “will,” “would,” or the detrimental of those phrases or different comparable terminology. However, not all forward-looking statements comprise these phrases. Forward-looking statements usually are not a assure of future efficiency or outcomes and won’t essentially be correct indications of the instances at which such efficiency or outcomes are achieved. This press launch must be thought-about in all filings of the Companies contained within the Edgar Archives of the Securities and Exchange Commission at www.sec.gov.

CONTACT:

FMW Media Contacts:

Bryan Johnson
+1 (631) 766-7462
Bryan@NewToTheStreet.com

“New to The Street” Business Development Office
1-516-696-5900
Support@NewToTheStreet.com

A photograph accompanying this announcement is out there at https://www.globenewswire.com/NewsRoom/AttachmentNg/1299b139-ab8e-47f4-9d82-5eccc5f109a4



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here